The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
Please provide your email address to receive an email when new articles are posted on . Fears associated with needles may cause patients and caregivers to delay their use of epinephrine autoinjectors.
The FDA has granted approval to a larger vial size of nelarabine injection (SH-111) for use in treatment of adult and ...
The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections. The FDA recently approved the first once-weekly somatropin injection for pediatric patients 1 ...
Credit: Getty Images. The FDA has issued a safety alert regarding the use of unapproved potassium phosphates drug products in pediatric patients. The Food and Drug Administration (FDA) has issued a ...